| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-10 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |